US4166452A
(en)
*
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
US4256108A
(en)
|
1977-04-07 |
1981-03-17 |
Alza Corporation |
Microporous-semipermeable laminated osmotic system
|
US4704362A
(en)
|
1977-11-08 |
1987-11-03 |
Genentech, Inc. |
Recombinant cloning vehicle microbial polypeptide expression
|
US4265874A
(en)
*
|
1980-04-25 |
1981-05-05 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
US4495002A
(en)
*
|
1981-05-27 |
1985-01-22 |
Westinghouse Electric Corp. |
Three-step treatment of stainless steels having metastable austenitic and martensitic phases to increase resistance to chloride corrosion
|
US5462856A
(en)
*
|
1990-07-19 |
1995-10-31 |
Bunsen Rush Laboratories, Inc. |
Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins
|
JPH07504158A
(ja)
|
1991-10-22 |
1995-05-11 |
ニュー イングランド メディカル センター ホスピタルズ インク |
ジペプチジル−アミノペプチダーゼiv型のインヒビタ
|
MX9206628A
(es)
|
1991-11-22 |
1993-05-01 |
Boehringer Ingelheim Pharma |
Ester de prolinaboronato y metodo para su preparacion.
|
US6100042A
(en)
*
|
1993-03-31 |
2000-08-08 |
Cadus Pharmaceutical Corporation |
Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
|
US20020006899A1
(en)
|
1998-10-06 |
2002-01-17 |
Pospisilik Andrew J. |
Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals
|
DE19616486C5
(de)
|
1996-04-25 |
2016-06-30 |
Royalty Pharma Collection Trust |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
TW492957B
(en)
|
1996-11-07 |
2002-07-01 |
Novartis Ag |
N-substituted 2-cyanopyrrolidnes
|
US6100234A
(en)
|
1997-05-07 |
2000-08-08 |
Tufts University |
Treatment of HIV
|
US6040145A
(en)
|
1997-05-07 |
2000-03-21 |
Tufts University |
Potentiation of the immune response
|
US6183974B1
(en)
|
1997-07-31 |
2001-02-06 |
The General Hospital Corporation |
Screening assays for G protein coupled receptor agonists and antagonists
|
GB9719496D0
(en)
|
1997-09-13 |
1997-11-19 |
Glaxo Group Ltd |
G protien chimeras
|
WO1999025719A1
(fr)
|
1997-11-18 |
1999-05-27 |
Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai |
Substance physiologiquement active, la sulphostine, procede de fabrication et utilisation
|
EP2574336A1
(en)
|
1998-02-02 |
2013-04-03 |
Trustees Of Tufts College |
Use of dipeptidylpeptidase inhibitors to regulate glucose metabolism
|
US5922576A
(en)
|
1998-02-27 |
1999-07-13 |
The John Hopkins University |
Simplified system for generating recombinant adenoviruses
|
US6304621B1
(en)
|
1998-05-13 |
2001-10-16 |
Broadcom Corporation |
Multi-mode variable rate digital cable receiver
|
DE19823831A1
(de)
|
1998-05-28 |
1999-12-02 |
Probiodrug Ges Fuer Arzneim |
Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
|
DE19828114A1
(de)
|
1998-06-24 |
2000-01-27 |
Probiodrug Ges Fuer Arzneim |
Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
|
DE19828113A1
(de)
|
1998-06-24 |
2000-01-05 |
Probiodrug Ges Fuer Arzneim |
Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
|
DE19834591A1
(de)
|
1998-07-31 |
2000-02-03 |
Probiodrug Ges Fuer Arzneim |
Verfahren zur Steigerung des Blutglukosespiegels in Säugern
|
RU2207161C2
(ru)
|
1998-08-06 |
2003-06-27 |
Пельц Самуил Давидович |
Способ и устройства электростимуляции
|
BR9913153A
(pt)
|
1998-08-21 |
2001-05-15 |
Point Therapeutics Inc |
Normalização da atividade do substrato
|
WO2000012704A2
(en)
|
1998-09-01 |
2000-03-09 |
Basf Aktiengesellschaft |
Enhanced functional expression of g protein-coupled receptors
|
EP1119625B1
(en)
|
1998-10-07 |
2005-06-29 |
Medical College Of Georgia Research Institute, Inc. |
Glucose-dependent insulinotropic peptide for use as an osteotropic hormone
|
US6242422B1
(en)
|
1998-10-22 |
2001-06-05 |
Idun Pharmacueticals, Inc. |
(Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
|
NZ511087A
(en)
|
1998-11-20 |
2004-01-30 |
Arena Pharm Inc |
Human orphan G protein-coupled receptors
|
CO5150173A1
(es)
|
1998-12-10 |
2002-04-29 |
Novartis Ag |
Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
|
JP2000191616A
(ja)
|
1998-12-24 |
2000-07-11 |
Senju Pharmaceut Co Ltd |
新規ジペプチジルアルデヒド誘導体およびそれを含有する医薬
|
US6221660B1
(en)
*
|
1999-02-22 |
2001-04-24 |
Synaptic Pharmaceutical Corporation |
DNA encoding SNORF25 receptor
|
US20030125539A1
(en)
*
|
1999-02-22 |
2003-07-03 |
Synaptic Pharmaceutical Corporation |
DNA encoding SNORF25 receptor
|
JP4121215B2
(ja)
|
1999-05-17 |
2008-07-23 |
財団法人微生物化学研究会 |
スルフォスチン類縁体、並びにスルフォスチン及びその類縁体の製造方法
|
JP4028135B2
(ja)
|
1999-05-27 |
2007-12-26 |
本田技研工業株式会社 |
物体検出装置
|
US6617340B1
(en)
|
1999-07-29 |
2003-09-09 |
Novartis Ag |
N-(substituted glycyl)-pyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
DE19940130A1
(de)
|
1999-08-24 |
2001-03-01 |
Probiodrug Ges Fuer Arzneim |
Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung
|
US6653064B1
(en)
|
1999-09-23 |
2003-11-25 |
Boehringer Ingelheim International Gmbh |
Method for identifying compounds useful in the therapy of bone disorders
|
GB9923177D0
(en)
|
1999-09-30 |
1999-12-01 |
Pfizer Ltd |
Novel polypeptide
|
WO2001034594A1
(en)
|
1999-11-12 |
2001-05-17 |
Guilford Pharmaceuticals, Inc. |
Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
|
US6380398B2
(en)
|
2000-01-04 |
2002-04-30 |
Novo Nordisk A/S |
Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV
|
JP2003520226A
(ja)
|
2000-01-21 |
2003-07-02 |
ノバルティス アクチエンゲゼルシャフト |
ジペプチジルペプチダーゼ−iv阻害剤および抗糖尿病薬剤を含む組合せ物
|
US6395767B2
(en)
|
2000-03-10 |
2002-05-28 |
Bristol-Myers Squibb Company |
Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
|
US6608038B2
(en)
|
2000-03-15 |
2003-08-19 |
Novartis Ag |
Methods and compositions for treatment of diabetes and related conditions via gene therapy
|
AU2001257169C1
(en)
|
2000-04-21 |
2011-06-16 |
Tufts Medical Center, Inc. |
G-protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same
|
GB0010183D0
(en)
|
2000-04-26 |
2000-06-14 |
Ferring Bv |
Inhibitors of dipeptidyl peptidase IV
|
GB0010188D0
(en)
|
2000-04-26 |
2000-06-14 |
Ferring Bv |
Inhibitors of dipeptidyl peptidase IV
|
PT1287133E
(pt)
*
|
2000-05-18 |
2007-03-30 |
Bayer Healthcare Ag |
Regulação do receptor acoplado à proteína g tipo dopamina humano
|
TW583185B
(en)
|
2000-06-13 |
2004-04-11 |
Novartis Ag |
N-(substituted glycyl)-2-cyanopyrrolidines and pharmaceutical composition for inhibiting dipeptidyl peptidase-IV (DPP-IV) or for the prevention or treatment of diseases or conditions associated with elevated levels of DPP-IV comprising the same
|
US6432969B1
(en)
|
2000-06-13 |
2002-08-13 |
Novartis Ag |
N-(substituted glycyl)-2 cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
AU2001268958B2
(en)
|
2000-07-04 |
2006-03-09 |
Novo Nordisk A/S |
Heterocyclic compounds, which are inhibitors of the enzyme dpp-iv
|
AU7705601A
(en)
*
|
2000-07-25 |
2002-02-05 |
Merck & Co Inc |
N-substituted indoles useful in the treatment of diabetes
|
EP1950199B1
(en)
|
2000-08-10 |
2009-12-02 |
Mitsubishi Tanabe Pharma Corporation |
Proline derivatives and use thereof as drugs
|
US20040005555A1
(en)
|
2000-08-31 |
2004-01-08 |
Rothman Richard E. |
Molecular diagnosis of bactermia
|
IL154893A0
(en)
|
2000-10-06 |
2003-10-31 |
Tanabe Seiyaku Co |
Aliphatic nitrogen-containing cyclic compounds, methods for the preparation thereof and pharmaceutical compositions containing the same
|
JP4329291B2
(ja)
|
2000-10-06 |
2009-09-09 |
田辺三菱製薬株式会社 |
含窒素五員環化合物
|
JP4329290B2
(ja)
|
2000-10-06 |
2009-09-09 |
田辺三菱製薬株式会社 |
脂肪族含窒素五員環化合物
|
JP2004035574A
(ja)
|
2000-10-06 |
2004-02-05 |
Tanabe Seiyaku Co Ltd |
脂肪族含窒素五員環化合物
|
TWI243162B
(en)
|
2000-11-10 |
2005-11-11 |
Taisho Pharmaceutical Co Ltd |
Cyanopyrrolidine derivatives
|
AU1989002A
(en)
|
2000-11-27 |
2002-06-03 |
Arena Pharm Inc |
Endogenous and non-endogenous versions of human g protein-coupled receptors
|
ATE348152T1
(de)
|
2000-12-01 |
2007-01-15 |
Astellas Pharma Inc |
Verfahren zum screening von diabetes- heilverfahren
|
US20040180925A1
(en)
|
2000-12-27 |
2004-09-16 |
Kenji Matsuno |
Dipeptidylpeptidase-IV inhibitor
|
JP4823431B2
(ja)
|
2001-01-30 |
2011-11-24 |
東レ・ダウコーニング株式会社 |
室温硬化性シリコーンゴム組成物
|
JP4213390B2
(ja)
|
2001-02-02 |
2009-01-21 |
武田薬品工業株式会社 |
縮合複素環化合物
|
PT1953162E
(pt)
|
2001-02-24 |
2012-07-13 |
Boehringer Ingelheim Pharma |
Derivados de xantina, sua preparação e sua utilização como produto farmacêutico
|
JP2002265439A
(ja)
|
2001-03-08 |
2002-09-18 |
Mitsubishi Pharma Corp |
シアノピロリジン誘導体およびその医薬用途
|
EA006556B1
(ru)
|
2001-03-27 |
2006-02-24 |
Те Риджентс Оф Те Юниверсити Оф Калифорния |
Способы, соединения и композиции для борьбы с ожирением и регулирования метаболизма жирных кислот
|
EP1385508B1
(en)
|
2001-03-27 |
2008-05-21 |
Merck & Co., Inc. |
Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
FR2822826B1
(fr)
|
2001-03-28 |
2003-05-09 |
Servier Lab |
Nouveaux derives sulfonyles d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
US6573287B2
(en)
|
2001-04-12 |
2003-06-03 |
Bristo-Myers Squibb Company |
2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
|
US20020192206A1
(en)
|
2001-05-05 |
2002-12-19 |
Kozarov Emil V. |
Methods and compositions for angioproliferative disorder treatment
|
FR2824825B1
(fr)
|
2001-05-15 |
2005-05-06 |
Servier Lab |
Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
JP2003000977A
(ja)
|
2001-06-26 |
2003-01-07 |
Juki Corp |
玉縁縫製用ミシンの袋布地供給装置
|
US7368421B2
(en)
|
2001-06-27 |
2008-05-06 |
Probiodrug Ag |
Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis
|
US20030130199A1
(en)
|
2001-06-27 |
2003-07-10 |
Von Hoersten Stephan |
Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
|
US6869947B2
(en)
|
2001-07-03 |
2005-03-22 |
Novo Nordisk A/S |
Heterocyclic compounds that are inhibitors of the enzyme DPP-IV
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
US6740250B2
(en)
|
2001-07-13 |
2004-05-25 |
Hazard Control Technologies |
Fire suppressant having foam stabilizer
|
DE10143840A1
(de)
|
2001-09-06 |
2003-03-27 |
Probiodrug Ag |
Neue Inhibitoren der Dipeptidylpeptidase I
|
US6844316B2
(en)
|
2001-09-06 |
2005-01-18 |
Probiodrug Ag |
Inhibitors of dipeptidyl peptidase I
|
WO2003026661A1
(fr)
|
2001-09-14 |
2003-04-03 |
Yamanouchi Pharmaceutical Co., Ltd. |
Accelerateur de secretion de l'insuline et nouveau derive de pyrimidine
|
KR20040033048A
(ko)
|
2001-09-14 |
2004-04-17 |
미츠비시 웰파마 가부시키가이샤 |
티아졸리딘 유도체 및 이의 약학적 용도
|
EP1463727A2
(en)
|
2001-09-19 |
2004-10-06 |
Novo Nordisk A/S |
Heterocyclic compounds that are inhibitors of the enzyme dpp-iv
|
US7238671B2
(en)
|
2001-10-18 |
2007-07-03 |
Bristol-Myers Squibb Company |
Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
|
CA2463908A1
(en)
|
2001-10-18 |
2003-04-24 |
Bristol-Myers Squibb Company |
Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
|
GB0125446D0
(en)
|
2001-10-23 |
2001-12-12 |
Ferring Bv |
Novel anti-diabetic agents
|
US6861440B2
(en)
|
2001-10-26 |
2005-03-01 |
Hoffmann-La Roche Inc. |
DPP IV inhibitors
|
US20030125304A1
(en)
|
2001-11-09 |
2003-07-03 |
Hans-Ulrich Demuth |
Substituted amino ketone compounds
|
EP2769715A3
(en)
|
2001-11-26 |
2014-09-17 |
Trustees Of Tufts College |
Methods for treating autoimmune disorders, and reagents related thereto
|
CA2468192A1
(en)
|
2001-11-26 |
2003-06-05 |
Trustees Of Tufts College |
Peptidomimetic inhibitors of post-proline cleaving enzymes
|
AU2002360732A1
(en)
|
2001-12-26 |
2003-07-24 |
Guilford Pharmaceuticals |
Change inhibitors of dipeptidyl peptidase iv
|
US6727261B2
(en)
|
2001-12-27 |
2004-04-27 |
Hoffman-La Roche Inc. |
Pyrido[2,1-A]Isoquinoline derivatives
|
CA2475653A1
(en)
|
2002-02-08 |
2003-09-04 |
Idun Pharmaceuticals, Inc. |
(substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
|
CA2474578C
(en)
|
2002-02-13 |
2009-08-25 |
F. Hoffmann-La Roche Ag |
Novel pyridin- and pyrimidin-derivatives
|
AU2003206834B2
(en)
|
2002-02-13 |
2006-10-19 |
F. Hoffmann-La Roche Ag |
Novel pyridine- and quinoline-derivatives
|
US6906074B2
(en)
|
2002-02-22 |
2005-06-14 |
Nippon Zoki Pharmaceutical Co., Ltd. |
2-phenylpiperazine derivatives
|
EP1338595B1
(en)
|
2002-02-25 |
2006-05-03 |
Eisai Co., Ltd. |
Xanthine derivatives as DPP-IV inhibitors
|
JP2004043429A
(ja)
|
2002-02-25 |
2004-02-12 |
Eisai Co Ltd |
新規キサンチン誘導体およびdppiv阻害剤
|
SI1480961T1
(sl)
|
2002-02-28 |
2007-06-30 |
Prosidion Ltd |
Inhibitorji dpiv na osnovi glutaminila
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
DE60322857D1
(de)
|
2002-03-25 |
2008-09-25 |
Nippon Kayaku Kk |
Neues alpha-amino-n-(diaminophosphinyl)lactamderivat
|
US7307164B2
(en)
|
2002-03-25 |
2007-12-11 |
Merck & Co., Inc. |
β-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
JP4329381B2
(ja)
|
2002-04-04 |
2009-09-09 |
田辺三菱製薬株式会社 |
医薬組成物
|
JP4329382B2
(ja)
|
2002-04-04 |
2009-09-09 |
田辺三菱製薬株式会社 |
医薬組成物
|
CN1633420A
(zh)
|
2002-04-08 |
2005-06-29 |
托伦脱药品有限公司 |
噻唑烷-4-腈和类似物以及它们作为二肽基-肽酶抑制剂的用途
|
JP2003300977A
(ja)
|
2002-04-10 |
2003-10-21 |
Sumitomo Pharmaceut Co Ltd |
キサンチン誘導体
|
JP2004026820A
(ja)
|
2002-05-09 |
2004-01-29 |
Taisho Pharmaceut Co Ltd |
ジペプチジルペプチダーゼiv阻害剤
|
JP2003327532A
(ja)
|
2002-05-10 |
2003-11-19 |
Takeda Chem Ind Ltd |
ペプチダーゼ阻害剤
|
US6710040B1
(en)
|
2002-06-04 |
2004-03-23 |
Pfizer Inc. |
Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors
|
AU2003233010A1
(en)
|
2002-06-04 |
2003-12-19 |
Pfizer Products Inc. |
Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
|
BR0311697A
(pt)
|
2002-06-06 |
2005-03-22 |
Eisai Co Ltd |
Novos derivados condensados de imidazol
|
JP2004026678A
(ja)
|
2002-06-24 |
2004-01-29 |
Microbial Chem Res Found |
2型糖尿病治療剤
|
US6833973B2
(en)
|
2002-06-27 |
2004-12-21 |
International Business Machines Corporation |
Apparatus and method to calibrate a servo sensor
|
DE60330485D1
(de)
|
2002-07-15 |
2010-01-21 |
Merck & Co Inc |
Zur behandlung von diabetes
|
JP4542757B2
(ja)
|
2002-08-08 |
2010-09-15 |
武田薬品工業株式会社 |
縮合複素環化合物
|
US20050101542A1
(en)
|
2002-08-20 |
2005-05-12 |
Regents Of The University Of California |
Combination therapy for controlling appetites
|
US7407955B2
(en)
|
2002-08-21 |
2008-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
DE10238243A1
(de)
|
2002-08-21 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
DE10238477A1
(de)
|
2002-08-22 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Purinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
DE10238470A1
(de)
|
2002-08-22 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
EP1537880A4
(en)
|
2002-09-11 |
2009-07-01 |
Takeda Pharmaceutical |
PREPARATION FOR PROLONGED RELEASE
|
WO2004024943A1
(ja)
|
2002-09-11 |
2004-03-25 |
Yamanouchi Pharmaceutical Co., Ltd. |
インスリン含量増加剤スクリーニング方法
|
US7482337B2
(en)
|
2002-11-08 |
2009-01-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
DE10251927A1
(de)
|
2002-11-08 |
2004-05-19 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
MXPA05005260A
(es)
|
2002-11-18 |
2005-07-25 |
Pfizer Prod Inc |
Amidas ciclicas fluoradas que inhiben la dipeptidil peptidasa iv.
|
DE10256264A1
(de)
|
2002-12-03 |
2004-06-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue substituierte Imidazo-pyridinone und Imidazo-pyridazinone, ihre Herstellung und ihre Verwendung als Arzneimittel
|
EP1578414A4
(en)
|
2002-12-04 |
2007-10-24 |
Merck & Co Inc |
PHENYLALANINE DERIVATIVES ALSDIPEPTIDYL-PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
|
CA2508947A1
(en)
|
2002-12-20 |
2004-07-15 |
Merck & Co., Inc. |
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
ATE374766T1
(de)
|
2003-01-14 |
2007-10-15 |
Arena Pharm Inc |
1,2,3-trisubstituierte aryl- und heteroarylderivate als modulatoren des metabolismus zur vorbeugung und behandlung von metabolismus-bedingten krankheiten wie diabetes oder hyperglykämie
|
US7265128B2
(en)
|
2003-01-17 |
2007-09-04 |
Merck & Co., Inc. |
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
JP2004244412A
(ja)
|
2003-01-20 |
2004-09-02 |
Kotobuki Seiyaku Kk |
4位に置換基を有する2−シアノピロリジン誘導体及びその製造方法並びにそれを含有する薬剤
|
AU2004210149A1
(en)
|
2003-01-31 |
2004-08-19 |
Merck & Co., Inc. |
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
ES2316964T3
(es)
|
2003-02-24 |
2009-04-16 |
Arena Pharmaceuticals, Inc. |
Fenil-y piridilpipereidinia-derivados como moduladores del metabolismo de la glucosa.
|
JP2004269469A
(ja)
|
2003-03-12 |
2004-09-30 |
Yamanouchi Pharmaceut Co Ltd |
ピリミジン誘導体又はその塩
|
JP2004269468A
(ja)
|
2003-03-12 |
2004-09-30 |
Yamanouchi Pharmaceut Co Ltd |
ピリミジン誘導体又はその塩
|
US7371871B2
(en)
|
2003-05-05 |
2008-05-13 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase
|
US7083933B1
(en)
|
2003-05-09 |
2006-08-01 |
Prosidion Limited |
Methods for identification of modulators of OSGPR116 activity
|
EP1625122A1
(en)
|
2003-05-14 |
2006-02-15 |
Takeda San Diego, Inc. |
Dipeptidyl peptidase inhibitors
|
WO2004103276A2
(en)
|
2003-05-14 |
2004-12-02 |
Merck & Co., Inc. |
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
JPWO2004101514A1
(ja)
|
2003-05-15 |
2006-07-13 |
大正製薬株式会社 |
シアノフルオロピロリジン誘導体
|
DE10327439A1
(de)
|
2003-06-18 |
2005-01-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Imidazopyridazinon- und Imidazopyridonderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
ES2355105T3
(es)
|
2003-06-20 |
2011-03-22 |
F. Hoffmann-La Roche Ag |
Pirido(2,1-a)isoquinolina como inhibidores de la dpp-iv.
|
RU2339636C2
(ru)
|
2003-06-20 |
2008-11-27 |
Ф.Хоффманн-Ля Рош Аг |
Гексагидропиридоизохинолины в качестве ингибиторов дипептидилпептидазы iv (dpp-iv)
|
JP2005019000A
(ja)
|
2003-06-23 |
2005-01-20 |
Inter Media:Kk |
照明制御システム
|
JO2625B1
(en)
|
2003-06-24 |
2011-11-01 |
ميرك شارب اند دوم كوربوريشن |
Phosphoric acid salts of dipeptidyl betidase inhibitor 4
|
JP2005018412A
(ja)
|
2003-06-26 |
2005-01-20 |
Toppan Printing Co Ltd |
電子購買システム及び方法
|
JP2005023038A
(ja)
|
2003-07-04 |
2005-01-27 |
Taisho Pharmaceut Co Ltd |
慢性腎疾患治療薬
|
AR045047A1
(es)
*
|
2003-07-11 |
2005-10-12 |
Arena Pharm Inc |
Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
|
MXPA06000554A
(es)
|
2003-07-14 |
2006-07-03 |
Arena Pharm Inc |
Derivados arilo y heteroarilo fusionados como moduladores del metabolismo y la profilaxis y tratamiento de trastornos relacionados con los mismos.
|
US7008957B2
(en)
|
2003-07-25 |
2006-03-07 |
Sanofi-Aventis Deutschland Gmbh |
Bicyclic cyanoheterocycles, process for their preparation and their use as medicaments
|
DE10333935A1
(de)
|
2003-07-25 |
2005-02-24 |
Aventis Pharma Deutschland Gmbh |
Neue bicyclische Cyanoheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
US7094800B2
(en)
|
2003-07-25 |
2006-08-22 |
Sanofi-Aventis Deutschland Gmbh |
Cyanopyrrolidides, process for their preparation and their use as medicaments
|
US6995183B2
(en)
|
2003-08-01 |
2006-02-07 |
Bristol Myers Squibb Company |
Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
|
WO2005019168A2
(en)
|
2003-08-20 |
2005-03-03 |
Pfizer Products Inc. |
Fluorinated lysine derivatives as dipeptidyl peptidase iv inhibitors
|
US20070082908A1
(en)
|
2003-08-29 |
2007-04-12 |
Dainippon Sumitomo Pharma Co., Ltd. |
Bicycle pyrazole derivative
|
HU227684B1
(en)
|
2003-08-29 |
2011-11-28 |
Sanofi Aventis |
Adamantane and azabicyclo-octane and nonane derivatives and their use as dpp-iv inhibitors
|
ATE534404T1
(de)
|
2003-10-03 |
2011-12-15 |
Takeda Pharmaceutical |
Dipeptidylpeptidase-iv-inhibitoren zur behandlung von diabetes-patienten mit sekundärversagen durch sulfonylharnstoffe
|
DE10355304A1
(de)
*
|
2003-11-27 |
2005-06-23 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 8-(Piperazin-1-yl)-und 8-([1,4]Diazepan-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
US7217711B2
(en)
*
|
2003-12-17 |
2007-05-15 |
Boehringer Ingelheim International Gmbh |
Piperazin-1-yl and 2-([1,4]diazepan-1-yl)-imidazo[4,5-d]-pyridazin-4-ones, the preparation thereof and their use as pharmaceutical compositions
|
CN1898235A
(zh)
|
2003-12-24 |
2007-01-17 |
普罗西迪恩有限公司 |
作为gpcr受体激动剂的杂环衍生物
|
US7501426B2
(en)
*
|
2004-02-18 |
2009-03-10 |
Boehringer Ingelheim International Gmbh |
8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
|
DE102004009039A1
(de)
*
|
2004-02-23 |
2005-09-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und Verwendung als Arzneimittel
|
PL1756084T3
(pl)
|
2004-06-04 |
2009-06-30 |
Arena Pharm Inc |
Podstawione pochodne arylowe i heteroarylowe jako modulatory metabolizmu oraz profilaktyka i leczenie zaburzeń z metabolizmem związanych
|
CA2568857A1
(en)
|
2004-06-24 |
2006-01-05 |
Galapagos N.V. |
Lxr agonists to promote bone homeostasis
|
US20060024313A1
(en)
|
2004-07-06 |
2006-02-02 |
Xin Chen |
Agents that disrupt dimer formation in DPP-IV family of prolyl dipeptidases
|
WO2006019965A2
(en)
|
2004-07-16 |
2006-02-23 |
Takeda San Diego, Inc. |
Dipeptidyl peptidase inhibitors
|
US20060046978A1
(en)
|
2004-08-31 |
2006-03-02 |
Morphochem Ag |
Novel compounds that inhibit dipeptidyl peptidase (DPP-IV) and neprilysin (NEP) and/or angiotensin converting enzyme (ACE)
|
DE102004044221A1
(de)
|
2004-09-14 |
2006-03-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 3-Methyl-7-butinyl-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
AU2005294506A1
(en)
*
|
2004-10-07 |
2006-04-20 |
Merck Sharp & Dohme Corp. |
Acyclic hydrazides as cannabinoid receptor modulators
|
WO2006040966A1
(ja)
|
2004-10-08 |
2006-04-20 |
Astellas Pharma Inc. |
芳香環縮合ピリミジン誘導体
|
TW200621257A
(en)
|
2004-10-20 |
2006-07-01 |
Astellas Pharma Inc |
Pyrimidine derivative fused with nonaromatic ring
|
US7411093B2
(en)
|
2004-12-20 |
2008-08-12 |
Hoffman-La Roche Inc. |
Aminocycloalkanes as DPP-IV inhibitors
|
EP1828192B1
(en)
|
2004-12-21 |
2014-12-03 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
MX2007007553A
(es)
|
2004-12-24 |
2007-08-15 |
Prosidion Ltd |
Agonistas del receptor acoplado a proteina g (gpr116) y uso de los mismos para tratar obesidad y diabetes.
|
JP5065908B2
(ja)
|
2004-12-24 |
2012-11-07 |
プロシディオン・リミテッド |
Gタンパク質結合受容体作動薬
|
US7589088B2
(en)
|
2004-12-29 |
2009-09-15 |
Bristol-Myers Squibb Company |
Pyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
|
GB0428514D0
(en)
|
2004-12-31 |
2005-02-09 |
Prosidion Ltd |
Compounds
|
MY148521A
(en)
|
2005-01-10 |
2013-04-30 |
Arena Pharm Inc |
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
|
DOP2006000008A
(es)
|
2005-01-10 |
2006-08-31 |
Arena Pharm Inc |
Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
|
US20070032420A1
(en)
|
2005-02-09 |
2007-02-08 |
Entelos, Inc. |
Treating diabetes with glucagon-like peptide-1 secretagogues
|
WO2006132406A1
(ja)
|
2005-06-09 |
2006-12-14 |
Banyu Pharmaceutical Co., Ltd. |
下痢を伴う疾患の治療剤としてのnpy y2アゴニスト
|
JP2008545008A
(ja)
|
2005-06-30 |
2008-12-11 |
プロシディオン・リミテッド |
Gpcrアゴニスト
|
KR20080027908A
(ko)
|
2005-06-30 |
2008-03-28 |
프로시디온 리미티드 |
Gpcr 효능제
|
US20090325924A1
(en)
|
2005-06-30 |
2009-12-31 |
Stuart Edward |
GPCR Agonists
|
MX2007016545A
(es)
|
2005-06-30 |
2008-02-21 |
Prosidion Ltd |
Agonistas del receptor acoplado a la proteina g.
|
US7708191B2
(en)
*
|
2005-07-28 |
2010-05-04 |
Edwin Vega |
Telebanking apparatus for transferring money or cash value between two parties in the same country or across national borders, for paying bills and browsing the internet
|
PE20071221A1
(es)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
|
JP4521838B2
(ja)
|
2006-04-11 |
2010-08-11 |
アリーナ ファーマシューティカルズ, インコーポレイテッド |
個体において骨質量を増加させるために有用である化合物を同定するためにgpr119受容体を用いる方法
|
AU2007291252A1
(en)
|
2006-08-30 |
2008-03-06 |
Inovacia Ab |
Pyridine compounds for treating GPR119 related disorders
|
EP2146210A1
(en)
|
2008-04-07 |
2010-01-20 |
Arena Pharmaceuticals, Inc. |
Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY
|